CA2239931A1 - Comprime pharmaceutique comprenant de la norfloxacine - Google Patents

Comprime pharmaceutique comprenant de la norfloxacine Download PDF

Info

Publication number
CA2239931A1
CA2239931A1 CA 2239931 CA2239931A CA2239931A1 CA 2239931 A1 CA2239931 A1 CA 2239931A1 CA 2239931 CA2239931 CA 2239931 CA 2239931 A CA2239931 A CA 2239931A CA 2239931 A1 CA2239931 A1 CA 2239931A1
Authority
CA
Canada
Prior art keywords
norfloxacin
tablets
tablet
dissolution
disintegrant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2239931
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2239931 priority Critical patent/CA2239931A1/fr
Publication of CA2239931A1 publication Critical patent/CA2239931A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA 2239931 1998-07-15 1998-07-15 Comprime pharmaceutique comprenant de la norfloxacine Abandoned CA2239931A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2239931 CA2239931A1 (fr) 1998-07-15 1998-07-15 Comprime pharmaceutique comprenant de la norfloxacine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2239931 CA2239931A1 (fr) 1998-07-15 1998-07-15 Comprime pharmaceutique comprenant de la norfloxacine

Publications (1)

Publication Number Publication Date
CA2239931A1 true CA2239931A1 (fr) 2000-01-15

Family

ID=29275848

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2239931 Abandoned CA2239931A1 (fr) 1998-07-15 1998-07-15 Comprime pharmaceutique comprenant de la norfloxacine

Country Status (1)

Country Link
CA (1) CA2239931A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521253B1 (en) 1998-09-03 2003-02-18 Astrazeneca Ab Immediate release tablet
WO2003103674A1 (fr) * 2002-06-06 2003-12-18 Bernard Charles Sherman Comprimes contenant de l'hydrochlorure de ciprofloxacine
EP1501485B1 (fr) 2002-04-23 2007-09-26 Novartis AG Comprime a forte charge en substance medicamenteuse
WO2014146775A1 (fr) * 2013-03-19 2014-09-25 Pharmathen S.A. Composition pharmaceutique comprenant un agent antibactérien de fluoroquinolone et son procédé de préparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521253B1 (en) 1998-09-03 2003-02-18 Astrazeneca Ab Immediate release tablet
US6875446B2 (en) 1998-09-03 2005-04-05 Astrazeneca Ab Method for prophylaxis and/or treatment of thromboembolism
EP1501485B1 (fr) 2002-04-23 2007-09-26 Novartis AG Comprime a forte charge en substance medicamenteuse
WO2003103674A1 (fr) * 2002-06-06 2003-12-18 Bernard Charles Sherman Comprimes contenant de l'hydrochlorure de ciprofloxacine
WO2014146775A1 (fr) * 2013-03-19 2014-09-25 Pharmathen S.A. Composition pharmaceutique comprenant un agent antibactérien de fluoroquinolone et son procédé de préparation

Similar Documents

Publication Publication Date Title
US5256699A (en) Dispersible tablet formulation of diclofenac acid free base
AU746889B2 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
EP0365480B1 (fr) Composition à disperser
CA2212309C (fr) Formes posologiques orales solides a liberation prolongee de medicaments faiblement solubles dans l'eau
KR100202154B1 (ko) 파라세타몰 및 돔페리돈을 함유한 필름 피복 정제
EP1458377A1 (fr) Compositions pharmaceutiques renfermant un agoniste partiel du recepteur 5ht4
JP2686215B2 (ja) 徐放性錠剤
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
US5879714A (en) Controlled-release pharmaceutical compositions
CA2239931A1 (fr) Comprime pharmaceutique comprenant de la norfloxacine
JPH08310969A (ja) 固形薬品組成物及びその製造方法
EP1458384A1 (fr) Comprimes d'amlopidine bezylate possedant une stabilite amelioree
US6737419B2 (en) Benazepril hydrochloride tablet formulations
EP0950419B1 (fr) Une préparation solide et sa méthode de production
EP0519371B1 (fr) Formes d'administrations solides et stabilisées de compositions à base de salicylate de choline métal carboxyméthylcellulose
US20030229101A1 (en) Tablets comprising ciprofloxacin hydrochloride
KR100374768B1 (ko) 염산 서트랄린 경구투여용 조성물
MXPA01002650A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
AU2005203095A1 (en) Granulates comprising a water soluble compound and cellulose
JPH09263536A (ja) テルフェナジンを含有する医薬組成物

Legal Events

Date Code Title Description
FZDE Dead